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Abstract
Study design Observational, population-based cohort study.
Objectives To evaluate the origin and contribution to excess of survival differences following non-traumatic spinal cord
injury (NTSCI) using etiology as proxy for variation in underlying health condition.
Setting Specialized rehabilitation centers in Switzerland.
Methods Medical record data collected by the Swiss Spinal Cord Injury cohort (SwiSCI) study were linked with mortality
information from the Swiss National Cohort. Considering contemporary theory and empirical evidence, a directed acyclic
graph (DAG) was developed to formally evaluate causal differences among NTSCI etiologies, relative to traumatic SCI
(TSCI). Statistical inference was contingent on hazard ratios (HRs) and marginal survival differences, derived using flexible
parametric modeling.
Results 3643 individuals (NTSCI= 1357; TSCI= 2286) diagnosed with SCI between 1990 and 2011 were included,
contributing a cumulative 41,344 person-years and 1323 deaths. Test statistics confirmed DAG-dataset consistency. As
compared to TSCI, mortality was elevated in all NTSCI etiological groups; malignant etiologies had the highest HRs (10;
95% CI, 8.0 to 14) followed by infection (2.6; 1.8 to 3.6) and vascular (2.5; 2.0 to 3.2) etiology groups. At the attained age of
55, the estimated reduction in survival among non-malignant etiologies was 9.4% (5.8 to 13) at 5 years and 17% (11 to 23) at
20 years.
Conclusions Causal differences in survival among NTSCI etiological groups are likely a result of chronic variation in health
conditions. This study supports the development of long-term interdisciplinary management and policy for individuals with
NTSCI, specific to etiology.
Introduction
Non-traumatic spinal cord injuries (NTSCI) are commonly
associated with elevated mortality and reduced life expec-
tancy [1–4]. The elevated risk of death is partly due to the
impact of the neurological impairments on functioning and
health, supported by the decline in survival with increasing
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level of spinal cord injury (SCI) severity. Yet, particularly
for NTSCI, etiology-specific variation in chronic health
conditions likely contribute to elevated mortality risk,
mainly through acquired NTSCI etiologies; these include
vascular disorders, neoplasms, and degenerative disc dis-
orders, and infection. Moreover, the available clinical and
epidemiological evidence regarding long-term functioning
following diagnosis, as well as life-expectancy estimates
suggest that even temporally-defined clinical events, such as
infection or infarction, may be indicative of systemic and
chronic differences in the health of persons with NTSCI of
different etiology [2, 5, 6].
In order to define the scope for improving survival out-
comes in NTSCI by adopting etiology-specific clinical
management and health policy, population-based studies are
needed that separate the mortality that is attributable to
NTSCI etiology from lesion-related or demographic-
attributable mortality. Such studies are timely in face of
the growth in incidence and prevalence of NTSCI [2, 7]. We
therefore used longitudinal data from a Swiss population-
based cohort study [8] and applied formal causal inference
methodology [9–11] to infer the strength of support for the
hypothesis that mortality differentials in NTSCI causally
relate to etiology group. Using the causal estimates for
mortality differentials, we also estimated the disparity in
survival that was directly attributable to etiology-specific
differences.
Methods
Study description and vital status
The present study used medical records data collected from
the Swiss Spinal Cord cohort study (SwiSCI), which
includes all SCI-specific rehabilitation centers in Switzer-
land [8]. Individuals aged 16 years or older that initiated
first SCI-rehabilitation between 1990 and 2011 were
included in the present study. SwiSCI does not include
disorders such as multiple sclerosis. Vital status data were
obtained with high reliability (85.5%) through probabilistic
data linkage with the Swiss National Cohort (SNC) using
birthdate, date of death (when available), age, sex, and
geocoded address, further described in-depth elsewhere [4].
The present study uses vital status data that was updated
until December 31, 2018.
Data management
International Spinal Cord Society (ISCoS) guidelines were
followed in the grouping of all variables [12, 13]. NTSCI
etiologies were grouped according to the International SCI
core datasets for non-traumatic spinal cord injury [13]. The
etiological categories included were identified as “acquired
abnormalities” within this core dataset, mainly from the
second level of classification, which included: ‘degenerative
disc disorder,’ ‘infection,’ ‘vascular disorder,’ ‘benign
tumor,’ and ‘malignant tumor.’ NTSCIs originating from
tumors ‘benign’ and ‘malignant’ were split at the third level
of classification, following previous research that has
identified strong survival differences between these groups
[3, 5, 6]. NTSCIs that originated from metabolic disorders,
inflammatory disease, radiation-related causes, and those of
an unclear origin were grouped into an ‘other’ category
(n= 98). The TSCI population in the present study is made
up of four major etiological groups, namely ‘transport-
related,’ ‘sports and leisure,’ ‘falls,’ and ‘other.’ The main
analysis utilized TSCI etiologies resulting from ‘transport-
related’ and ‘sports and leisure’ etiologies for reference to
NTSCI, as these etiological groups are least likely to be
linked to underlying health conditions [14]. In a further
sensitivity analysis, TSCIs due to ‘falls’ and ‘other’ were
additionally included. Lesion level and completeness were
combined into a four-level variable representing SCI
severity, namely ‘paraplegia, incomplete,’ ‘paraplegia,
complete,’ ‘tetraplegia, incomplete,’ and ‘tetraplegia, com-
plete.’ Paraplegia was defined as lesions between T1-S5.
Directed acyclic graph: graphical causal model
Causal inference is a formal methodology to achieve strong
inference in empirical research. Causality is deduced by
postulating and testing explanations of reality, relative to
their fit with the measured data [15, 16]. The present study
facilitated causal inference through the application of a
directed acyclic graph (DAG). A DAG is a type of causal
diagram that graphically encodes the hypothesized rela-
tionships between variables [16]. DAGs formalize causal
inference by distinct specification of the direct path between
the exposure and outcome variables of interest, i.e., the
pathway defining the causal question, as well as alternative
paths of association, which potentially induce bias. The
latter particularly concerns confounding and potential col-
liding pathways, which need accounting for in study design
and statistical analysis, as to minimize the risk of biased
inference. A DAG encodes conditional independency
statements that can be verified statistically against the data.
DAGitty (http://dagitty.net), an online-based platform was
used to build, edit, and support DAG evaluation [17].
Defining DAG parameters
The effective DAG that was developed for the present study
is presented in Fig. 1. ‘SCI etiology’ was defined as the
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exposure variable in the hypothesized DAG, which is used
as a proxy for the assumed, but unmeasured variation in
etiology-specific underlying health condition. NTSCI
etiology was posited previously as a potential indicator for
reduced survival, considering the differential life-
expectancy seen between etiological groups [1, 5, 7].
Etiology-specific variation in “Underlying health condi-
tions” was thus operationalized as the Latent parent of the
exposure (http://dagitty.net for additional detail on graph
terminology) [17]. ‘Survival time’ was defined as the out-
come variable. The unidirectional arrow from the exposure
to the outcome indicates the relationship for which causality
was inferred in the present study. An additional arrow from
the latent variable “underlying health conditions” to survi-
val time was included—to account for the potential for
unaccounted loss of survival directly caused by the under-
lying health condition.
An indirect causal influence is also represented by
inclusion of a mediator, namely, ‘SCI severity’ (Fig. 1).
This DAG therefore also hypothesizes that SCI etiology
indirectly impacts mortality through SCI severity. This
should be interpreted to mean that the NTSCI etiology,
itself causes the SCI severity, which in turn has an impact
on survival [5, 18, 19].
‘Age’ and ‘Sex’ define the confounding pathway, as they
influence both the exposure ‘SCI etiology’, and the outcome
‘Survival time’ (Fig. 1). The reasoning for inclusion of these
demographic factors as confounders is based on previous
research in the field of SCI [7, 20]. ‘Calendar period’
defines a further potential confounding pathway, given that
health survey and survival data from the Swiss general
population indicate that the survival has steadily increased
with calendar period, in addition to the declining risk of
death following NTSCI [3, 19, 21].
This DAG guided all statistical analysis. In order to
estimate survival differences across NTSCI etiological
groups, we included survival data from persons with a TSCI
etiology as a baseline reference. This baseline reference was
determined to estimate the additional effect of underlying
health conditions on survival, therefore the main analysis
implemented the baseline TSCI due to ‘Transport’ and
Sports/Leisure,’ as contemporary TSCI literature hypothe-
sizes that TSCI due to ‘Falls’ or ‘Other’ may be linked to an
underlying health condition [14]. It further facilitated the
development of the minimal sufficient adjustment set,
which identifies and characterizes the most critical variables
that need to be accounted for in the comparative statistical
models [16]. Using TSCI as a reference group additionally
strengthened control for confounding pathways (through
age and sex) in addition to the mediating pathway (through
SCI severity) in the estimation of survival differences
between NTSCI etiological groups—as well as relative
to TSCI.
Determining conditional independences
Directed-separation, also known as d-separation is a set of
criteria that describe how to interpret the statistical asso-
ciations or the conditional independences that are implied
by the DAG [22]. Testing these conditional independences
provides an internal consistency check on whether the DAG
is consistent with the effective dataset [23].
The R package dagitty implements the DAGitty web
application and was used to evaluate the DAG-dataset
consistency [23]. An internal check was applied to each
conditional independence implied by the hypothesized
DAG using logistic regression to calculate the root mean
square error of approximation (RMSEA) [24]. Values <0.1
were considered consistent with our hypothesis [25].
Statistical analysis
Statistical analyses were implemented using Stata software
version 16.1 (College Station, TX).
Descriptive analyses report raw numbers and percentages
stratified by etiological group, for age and length of stay, the
mean and interquartile range are additionally reported.
Participant’s time-at-risk began with date of SCI diag-
nosis, with study start time beginning on the date of
admission to first rehabilitation. Follow-up time was cen-
sored on the date of death, or the end of study (December
31, 2018), whichever came first. Kaplan–Meier estimates
were used to graphically display crude survival according to
etiology and to provide non-parametric estimates of median
survival of the NTSCI with respect to the TSCI population.
Flexible parametric survival models were used to esti-
mate hazard and survival functions between NTSCI and
TSCI [26]. The Bayesian information criterion (BIC) was
used to determine the minimal number of knots in the
model. Age effects were accounted for by splitting follow-
up time and apportioning quantities of follow-up time to the
appropriate age categories. For example, if an individual
was diagnosed with SCI at age 56 and died at the age of 64,
this person would contribute 4 years of follow-up time to
the age category “45–60 years” and 4 years to the “60–75
years” age group. Thus attained age was used as a timescale
to better account for age differences. Cohort effects via
calendar period were additionally accounted for through
time-splitting [27], allotting participants to contribute time
to different risk sets based on the time since diagnosis
(1990–1999, 2000–2009, 2010–2018), during which they
lived with their SCI. [26]. Hazard ratios (HRs), with TSCI
as the baseline reference were derived to estimate relative
mortality. As a sensitivity analysis, HRs were estimated
using TSCI from all causes (including TSCI due to ‘falls’
and ‘other’) as a baseline reference. Global significance
testing derived P-values and 95% confidence intervals. E-
DAG of assumed causal relationship
values, which gauge the strength of an estimate considering
the potential for unmeasured confounding, were addition-
ally reported with lower CIs alongside HRs [28].
Major NTSCI etiological groups were identified using a
post hoc analysis of Bonferroni-corrected pairwise com-
parisons of marginal linear predictions. The marginal sur-
vival differences in the NTSCI population compared to the
reference group were estimated for calculation of absolute
survival differences adjusted for sex, calendar period and
SCI severity, using the attained age of 55, the average age
of SCI diagnosis in this population, as the reference value
[26]. Major etiological groups identified in the post hoc
analysis (i.e. ‘non-malignant’ and ‘malignant’) were used to
compare with the baseline reference group. An additional
sensitivity analysis estimated the marginal survival differ-
ences in NTSCI using all cases of TSCI as the baseline.
Results
The study population is described in Table 1. The present
study includes 3643 individuals diagnosed with an SCI
between 1990 and 2011, resulting in a cumulative 41,344
person-years and 1323 deaths. Of these individuals, 38%
incurred an SCI from a non-traumatic origin. Vascular
disorders were the most common NTSCI etiological group
(27%) followed by degenerative disc disorders (25%).
Across all NTSCI etiologies, females represented between
33 to 56% of the study population. The median age at
diagnosis was 57 years in infection etiology, 58 years in
benign tumors, 63 years in malignant tumors, 64 years in
vascular etiology, and 65 in degenerative disc disorders.
The proportion of individuals with tetraplegia varied
between 13% (malignant tumor etiology) and 38% (infec-
tion etiology) among those with NTSCI (Table 1). Lesion
completeness ranged between 4.1% in degenerative disc
disorders up to 19% in NTSCIs due to malignant tumors.
Significant differences were observed between etiological
groups according to sex, age, SCI calendar period of onset,
and SCI severity. Descriptive statistics stratified by TSCI
etiology provided in Table S1.
Causal inference
Figure 1 illustrates the directed acyclic graph developed to
hypothesize the relationship between underlying health
conditions that precede the onset of NTSCI and mortality.
The hypothesized DAG specified six conditional inde-
pendences, or d-separation criteria, namely, (1) ‘Age at SCI
is independent of sex’, (2) ‘Age is independent of SCI
severity, given etiology’, (3) ‘Age is independent of
calendar period of onset’, (4) ‘SCI severity is independent
of sex, given etiology’, (5) ‘SCI severity is independent of
calendar period of onset, given etiology’, and (6) ‘Sex is
independent of calendar period of onset.’ RMSEA used for
estimating DAG-dataset consistency was below 0.1 for all
Table 1 Characteristics of study participants by SCI etiology.
Non-traumatic SCI, n (%)
Person characteristics Degenerative disc disorder Infection Vascular disorder Benign tumor Malignant tumor Other Traumatic SCI, n (%)
Overall survival characteristics
N persons at risk (%) 337 (9.3) 126 (3.5) 368 (10) 129 (3.5) 304 (8.3) 93 (2.6) 2286 (100)
Person-years at risk 3275 1256 3435 1461 1006 827 30,085
N deaths 154 51 201 50 236 47 584
Sex
Female 141 (42.1) 51 (40.8) 139 (37.8) 72 (55.8) 99 (32.6) 42 (45.2) 583 (25.5)
Male 194 (57.9) 74 (59.2) 229 (62.2) 57 (44.2) 205 (67.4) 51 (54.8) 1703 (74.5)
Age category
16–30 9 (2.7) 15 (11.9) 17 (4.6) 16 (12.4) 14 (4.6) 12 (12.9) 700 (30.6)
31–45 48 (14.2) 21 (16.7) 33 (9.0) 19 (14.7) 43 (14.1) 24 (25.8) 575 (25.2)
45–60 85 (25.2) 40 (31.7) 87 (23.6) 36 (27.9) 72 (23.7) 23 (24.7) 459 (20.1)
61–75 117 (34.7) 32 (25.4) 166 (45.1) 37 (28.7) 127 (41.8) 22 (23.7) 360 (15.7)
75+ 78 (23.2) 18 (14.3) 65 (17.7) 21 (16.3) 48 (15.8) 12 (12.9) 192 (8.4)
Calendar period of diagnosis
1990–2000 58 (17.2) 39 (31.0) 103 (28.0) 31 (24.0) 87 (28.6) 19 (20.4) 903 (39.5)
2000–2011 279 (82.8) 87 (69.0) 265 (72.0) 98 (76.0) 217 (71.4) 74 (79.6) 1,383 (60.5)
SCI severity
Paraplegia, incomplete 159 (50.5) 59 (50.9) 233 (65.5) 88 (71.5) 199 (68.9) 47 (53.4) 759 (34.2)
Paraplegia, complete 7 (2.2) 15 (12.9) 56 (15.7) 6 (4.9) 53 (18.3) 13 (14.8) 527 (23.7)
Tetraplegia, incomplete 146 (46.3) 36 (31.0) 57 (16.0) 29 (23.6) 33 (11.4) 26 (29.5) 709 (31.9)
Tetraplegia, complete 3 (1.0) 6 (5.2) 10 (2.8) 0 (0.0) 4 (1.4) 2 (2.3) 225 (10.1)
Overall n= 3643; NTSCI= 1357 with a cumulative of 41,344 person-years at risk; NTSCI= 11,260.
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d-separation criteria (Table 2). For example, the RMSEA
for independence testing of the d-separation ‘sex is inde-
pendent of calendar period of onset’ was 0.03; in testing the
independence of age and calendar period of onset, RMSEA
was 0.08 (Table 2).
Etiology-specific survival following NTSCI
Crude Kaplan–Meier survival curves for individual SCI
etiologies are shown in Fig. 2. Distinct differences are
depicted between TSCI and individual NTSCI etiological
groups, with malignant neoplasms indicating the sharpest
decline in survival.
Multivariable HR estimates for mortality risk in NTSCI
etiological groups (controlling for sex, age, calendar period
of SCI onset, SCI severity) are shown in Table 3. HRs
revealed strong differences in etiology compared to TSCI.
For instance, the mortality risk was 2.5 (95% CI, 2.0 to 3.2)
times greater in vascular-related NTSCIs compared to
TSCI. Comparatively, mortality risk for NTSCIs due to
benign tumors were 2.1 times greater, compared to TSCI
(95% CI, 1.5 to 3.0), corresponding to an E-value of 3.6
(lower CI: 3.78). Moreover, a post hoc analysis of pairwise
comparisons of marginal linear predictions identified three
major etiological groups, namely, ‘a’: TSCI, ‘b’: ‘non-
malignant etiologies followed by all ‘c’: ‘malignant neo-
plasms.’ This analysis confirmed that mortality was elevated
for all NTSCI etiologies as compared to TSCI (Table 3).
Furthermore, malignant tumors (‘c’) were additionally
associated with markedly higher mortality than the
remaining NTSCI etiology groups (‘b’). Effect sizes for
covariates controlled for in the model (sex, attained age,
calendar period of SCI, and SCI severity) all indicated an
increased risk of mortality (Table S2). The sensitivity ana-
lysis including all TSCI etiologies (i.e., including categories
‘Falls’ and ‘Other’) confirmed these etiological differences
in survival, albeit with slightly attenuated HRs (Table S3).
Marginal differences in survival according to major
etiological groups are shown in Fig. 3. Adjusted survival
differences using the average attained age of SCI onset, 55
years, as reference, depicted an increasing survival gap
between non-malignant NTSCIs as compared to TSCI. For
example, survival differences increase from 9.4% (5.8 to 13)
at 5 years following diagnosis, to nearly 17% (11 to 23) after
20 years. The discrepancy was even more pronounced when
comparing NTSCIs due to a malignant tumor to TSCI, with
a reduction in survival diverging to 50% (CI= 39 to 61%)
after 5 years following diagnosis. The sensitivity analysis
including all TSCI etiologies gave similar results (Fig. S1).
Discussion
This study supports inference that persons living with SCI of
non-traumatic origin are inherently exposed to excess mor-
tality that goes beyond mortality attributed to demographic
Table 2 DAG-dataset consistency evaluation.
Conditional independences RMSEA
Age⊥ Sex 0.0698
Age⊥ SCI severity | SCI etiology 0.0246
Age⊥ Calendar period of diagnosis 0.0820
SCI severity ⊥ Sex | SCI etiology 0.0627
SCI severity ⊥Calendar period of diagnosis | SCI etiology 0.0342
Sex⊥ Calendar period of diagnosis 0.0303
RMSEA root mean square error of approximation.
These estimates are reflective of a DAG-dataset consistency evalua-
tion, where the conditional independences illustrated above DAG were
checked with the dataset. Logistic regression was implemented to
calculate RMSEA. All RMSEA values were lower than 0.1 for all
conditional independence statements, which lends support to the
current model. Reading example (line 2): “Age is independent of SCI
Severity, conditional on Etiology”.
Fig. 2 Kaplan–Meier survival curve for NTSCI by etiological
group. Figure 2 illustrates the crude survival between etiological
groups.
Fig. 1 DAG of assumed causal relationship. Directed acyclic graph
for the estimation of impact of underlying health conditions on mor-
tality following NTSCI.
DAG of assumed causal relationship
factors, calendar period of onset, or SCI severity. In com-
parison with TSCI, regardless of etiology, individuals with
an NTSCI had a consistently elevated mortality risk,
excess mortality was greatest in those with a malignant
tumor origin. These mortality differentials were unlikely
due to unmeasured confounding given the magnitude of
the E-values for the respective mortality hazard ratios.
Furthermore, the stratified measure of NTSCI etiological
groups demonstrated a widening gap in survival differ-
ences with time since injury, compared to traumatic SCI.
Thus, evidence from this study supports the hypothesis
that etiological differences in NTSCI are indicative of
chronic variation in underlying health conditions.
The substantial reductions in absolute survival due to
underlying health conditions indicate the need and
potential for etiology-specific clinical care and policy. A
recent analysis on the cause of death in the Swiss NTSCI
population indicated cardiovascular disorders, neoplasms,
and immunodeficiency as potential focus areas for the
improvement of NTSCI-specific care [29]. NTSCIs due to
benign or malignant tumors showed particularly higher
mortality risk when compared to the reference group,
which increased with time since injury. This evidence
therefore has clear consequences for health policy and
necessitates multidisciplinary care, co-management, and
formally organized health-care guidelines. Transmural
Table 3 Relative mortality risk: univariable and multivariable hazard ratios from FPM survival model.
Characteristics Univariable estimates Multivariable estimatesa
Hazard ratio (95% CI) P-value Hazard ratio (95% CI) P-value E-value (lower 95% CI)
Etiology <0.0001 <0.0001
TSCI (baseline) Reference Reference a
Degenerative disc disorder 4.61 (3.70–5.75) 2.19 (1.70–2.82) b 3.80 (2.79)
Infection 4.14 (3.02–5.69) 2.55 (1.83–3.55) b 4.54 (3.06)
Vascular disorder 5.54 (4.49–6.82) 2.50 (1.96–3.20) b 4.44 (3.33)
Other 5.06 (3.62–7.08) 3.42 (2.36–4.96) b 6.30 (4.15)
Benign tumor 3.46 (2.52–4.75) 2.10 (1.48–2.99) b 3.62 (2.32)
Malignant tumor 18.52 (14.89–23.04) 10.43 (7.99–13.62) c 20.35 (15.46)
Letters a–c indicate group-level difference based on Bonferonni-corrected pairwise comparisons of marginal linear predictions in a post hoc
analysis.
aThe multivariable estimates are adjusting for sex, age, calendar period, and SCI severity.
Fig. 3 Marginal differences in absolute survival among NTSCI
etiologies as compared to TSCI. All figures are adjusted for sex, age,
calendar period of onset, and SCI severity. The figure on the left
estimates the absolute survival difference in NTSCIs due to a non-
malignant etiology, which included degenerative disc disorders,
infection, vascular disorders, benign tumors, and others. The figure on
the right illustrates survival differences in NTSCIs due to a malignant
tumor. TSCIs (stemming from transport and sports/leisure-related
injuries) was used as the reference group for both, with the gray area
representing the 95% CI. Marginal survival differences are adjusted for
sex, calendar period, and SCI severity, with the attained age of 55 was
used as a reference value, as this was a common age of diagnosis in the
present population. Survival was censored in cases of NTSCI due to a
malignant etiology to only 5 years, following adjustment for baseline
characteristics.
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care approaches which aim for continuity of patient care
and prevention could potentially serve as a model to
bridge connections between rehabilitation physicians,
family physicians, and homecare [30]. Therefore, results
from this study can serve as a benchmark for guiding
health-care systems and evidence-based policy. Imple-
mentation strategies of long-term treatment needs, which
take into consideration the underlying health conditions in
individual etiological groups, are essential. For example, a
contemporary framework which considers the practical
clinical management of individuals with NTSCI due to
tumors is acronymed: NOMPRS [31]. NOMPRS indicates
neurological status, oncologic status, medical comorbid-
ities, pain, rehabilitation team, and social support. Similar
structures and guidelines are needed for all NTSCI etio-
logical groups with the addition of supporting long-term
care. This would require inter-professional monitoring
and care to manage individualized prevention strategies,
based on the underlying health condition in coordination
with SCI-specific care.
The major strength of this study is the formal imple-
mentation of a causal inference approach to derive estimate
of the magnitude of reduced survival due to underlying
health conditions following NTSCI within a high-income
setting. Understanding the magnitude of survival inequities
across NTSCI etiological groups in a formalized causal
framework further provides a foundation for the develop-
ment of improvement strategies. Owing to the design of
SwiSCI, this study benefitted from a nationally representa-
tive sampling frame of individuals with SCI admitted to
specialized rehabilitation. Furthermore, traditional and
contemporary statistical methods were used to estimate
differential survival, as exemplified through use of
Kaplan–Meier survival curves as well as flexible parametric
survival modeling, which permitted the evaluation of excess
mortality, while accounting for sociodemographic and SCI-
specific characteristics.
However, given that the present study relied on medical
record data, an important limitation is the unavailability of
potentially relevant confounders such as smoking and
socioeconomic status; these factors, if included in the model
may have potentially reduced the estimated effect of
underlying health conditions on survival. Another issue is
the potential selection bias regarding the admission to a
specialized rehab hospital; this therefore limited the repre-
sentativeness of this study to the SCI population in Swit-
zerland that received specialized rehabilitation.
Furthermore, individual health state in the present study was
engendered by the latent variable ‘underlying health con-
ditions’ in the causal pathway which precipitates SCI
diagnosis. These underlying health conditions are therefore
hypothesized to cause both SCI etiology and survival time.
Our study strongly supported inference that underlying
health conditions cause etiological-specific differences in
survival. However, the pathways for clinical and biopsy-
chosocial intervention require further investigation.
In addition, TSCI (due to Sports/Leisure, Transport)
has not been proven to be an unbiased baseline reference
as these individuals with TSCI may have had underlying
health conditions which led to their injury. However,
sensitivity analyses (which included all cases of TSCI,
additionally due to falls and other causes) lent further
support to the idea that underlying health conditions
linked to NTSCI-specific etiology impacted survival to a
greater extent following NTSCI. This study was further
limited in its ability to discriminate SCI lesion level and
severity, as the ‘International Standards for Neurological
Classifications of Spinal Cord Injury’ score was not sys-
tematically measured until after the year 2001. Individuals
with high and severe lesions (C1-C4 AIS A, B) often
require respiratory assistance, which could impact the
magnitude of the survival differential between etiological
groups. Furthermore, length-time bias related to variant
onset between etiological groups could have resulted in an
underestimation of survival estimates, particularly for
diseases with prolonged onset (e.g., spinal stenosis).
However, we expect this would result in minimal bias on
differential survival, given the amount of follow-up time
in the present study. Finally, information on the specific
type of cancer related to the onset of neoplastic NTSCIs
was not available for further stratification.
The development and application of the DAG allowed
for a transparent representation of the causal assumptions in
this study and ultimately informed the methodological and
statistical approach. The d-separation criterion via P-values,
which link information on strength and sample size,
RMSEA was used to test effect sizes. However, it is
important to note that the check for DAG consistency with a
particular set of data can never imply formal proof of the
supposed association structure [22]. Therefore, international
comparisons of survival after NTSCI with respect to etiol-
ogy are needed to better inform the validity of the
current model.
Conclusion
The present study provides further evidence that sustained
underlying health conditions impact mortality differentials
following NTSCI, due to both non-malignant and malignant
etiologies. The disparate survival following NTSCI indi-
cates a need for targeted, long-term rehabilitation and pre-
vention strategies that account for individual health
conditions and implementations for interdisciplinary care.
Furthermore, by defining the scope of the differential sur-
vival patterns specific to NTSCI etiology can potentially
DAG of assumed causal relationship
benefit service paradigms that aim to improve secondary
prevention strategies through targeted clinical follow-up.
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